Dr. Bhojwani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4650 Sunset Blvd, MS54
Los Angeles, CA 90027Phone+1 323-361-2122
Education & Training
NYU Grossman School of MedicineFellowship, Pediatric Hematology/Oncology, 2001 - 2004
Woodhull Medical and Mental Health CenterResidency, Pediatrics, 1998 - 2001
M.S. Ramaiah Medical CollegeClass of 1994
Certifications & Licensure
CA State Medical License 2015 - 2026
NY State Medical License 2004 - 2026
TN State Medical License 2008 - 2015- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 215 citationsLong-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemiaC H Pui, Deqing Pei, Jt T. Sandlund, Rc C. Ribeiro, Je E. Rubnitz
Leukemia. 2010-02-01 - 148 citationsGenome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia.Jun J. Yang, Deepa Bhojwani, Wenjian Yang, Xiangjun Cai, Gabriele Stocco
Blood. 2008-11-15 - 41 citationsPhase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol...Maureen M O'Brien, Lingyun Ji, Nirali N Shah, Susan R Rheingold, Deepa Bhojwani
Journal of Clinical Oncology. 2022-03-20
Journal Articles
- Inotuzumab Ozogamicin in Pediatric Patients with relapsed/refractory Acute Lymphoblastic LeukemiaDeepa Bhojwani, Constance Yuan, Jennifer L McNeer, Mignon L Loh, Vilmarie Rodriguez, Susan R Rheingold, Elizabeth A Raetz, Nature
Abstracts/Posters
- Targeting of Integrin _4/VCAM-1 with AVA4746 Modulates the Redox-Status and Metabolism in ALL and AngiogenesisDeepa Bhojwani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Cell Adhesion of ALL to Stromal Cells May Mediate CAR T-Cell Resistance: A Novel Escape Mechanism for ImmunotherapyDeepa Bhojwani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results fro...Deepa Bhojwani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
- First Edition: March 12, 2021March 12th, 2021
- ‘An Accelerated Cauldron of Evolution’: Covid-19 Patients with Cancer, HIV, May Play a Role in Emergence of VariantsMarch 11th, 2021
- Can a Novel Approach Lead to Less-Toxic Treatments for Leukemia?December 2nd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
